Cleave Therapeutics, Inc.
VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases
3 employees · est. 2011 · San Francisco, United States
Cleave Therapeutics, Inc. is the older company (2020 vs 2011).
Side-by-Side Comparison
| Metric | Amyl Therapeutics | Cleave Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2011 older |
| Headquarters | ||
| Headquarters | Liege, Belgium | San Francisco, United States |
| Employees | ||
| Employees | 9 | 3 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Grant | Series C |
| Total Funding | ||
| Total Funding | $29.70M | $91.95M |
| Funding Rounds | ||
| Funding Rounds | 4 | 5 |
| Services | ||
| Services | Development of Pan-Amyloid Immunotherapy for amyloid-mediated diseases | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients suffering from amyloid-mediated diseases, healthcare providers, pharmaceutical companies, research institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Therapeutics, Preclinical Research, Neurodegenerative Diseases, Protein Misfolding, Amyloid Diseases, Drug Development, Biochemistry, Medical Research, Neuroscience, Pharmaceuticals, Biopharmaceutical Research, Clinical Trials, Disease Treatment, Medical Innovation | VCP/p97 Inhibitors, Oncology, Neurodegenerative Diseases, Biopharmaceutical, Protein Homeostasis, Cellular Stress Pathways, Cancer Stress Pathways, Drug Discovery, Drug Development, AML (Acute Myeloid Leukemia), Mitochondrial Health, Protein-Degradation Pathways, Small-Molecule Drugs, Selective Inhibitors, Therapeutic Innovation |
| Website | ||
| Website | amyltx.com | cleavetherapeutics.com |
About Amyl Therapeutics
Amyl Therapeutics is a preclinical-stage biotechnology company founded in 2020 and based in Belgium. The company's mission revolves around pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. With the slogan "Restoring clarity in amyloid diseases," Am...
About Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc., founded in 2011, is a pioneering biopharmaceutical company headquartered in the United States. It focuses on developing VCP/p97 inhibitors for applications in oncology and neurodegenerative diseases. The company positions itself as a leader in targeting the valosin-contain...
We will tell you when either one moves
BounceWatch watches Amyl Therapeutics and Cleave Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Amyl Therapeutics and Cleave Therapeutics, I... — by email.
Frequently Asked Questions
Compare Amyl Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Amyl Therapeutics on 13 Apr 2025, and Cleave Therapeutics, Inc. on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
